Thyra de Jongh

Principal Consultant

Les bureaux: Pays-Bas
Courriel: thyra.dejongh@technopolis-group.com

Thyra de Jongh is a Principal Consultant at Technopolis BV, with over 18 years of experience in research and consulting. Her main areas of expertise are pharmaceutical legislation and innovation, medical research, health systems and policy analysis and global health. She has performed studies, programme evaluations and impact assessments for a range of organisations. This has given her a thorough grounding in research methods such as interviews, literature reviews, case studies, surveys and workshops.  

Thyra joined Technopolis Group in 2014. Since then, her clients have included the European Commission, the World Health Organization, the European Centre for Disease Prevention and Control, numerous ministries and governmental agencies, research funders, non-governmental institutions and professional associations. She is currently the project leader for key projects in the areas of pharmaceutical regulation, vaccine communication, translational research and sexual and reproductive health. She was the project leader for the evaluation study for the EU Orphan Regulation for incentivising the development of medicines for rare diseases. 

Prior to joining Technopolis, Thyra worked for five years as a self-employed international health consultant. During this time, she conducted, among other things, evaluations of health programmes in Europe, Africa and the Middle-East for multilateral organisations. 

She holds Master’s degrees in Chemistry (University of Amsterdam, distinction) and International Health Management (Imperial College London, distinction), and in 2006 obtained a PhD in Biochemistry (University of Leiden). She has published a number of peer-reviewed articles and is fluent in Dutch and English. 

Since 2018, Thyra has been a member of the management team of Technopolis BV. 

Thyra de Jongh a écrit des articles.

Thyra de Jongh a écrit des rapports.